Prosecution Insights
Last updated: April 19, 2026
Application No. 17/904,039

POLYACRYLATE-FREE COSMETIC PREPARATION

Non-Final OA §103
Filed
Aug 11, 2022
Examiner
WARD, PAUL V
Art Unit
1622
Tech Center
1600 — Biotechnology & Organic Chemistry
Assignee
BEIERSDORF AG
OA Round
3 (Non-Final)
83%
Grant Probability
Favorable
3-4
OA Rounds
2y 7m
To Grant
72%
With Interview

Examiner Intelligence

Grants 83% — above average
83%
Career Allow Rate
1391 granted / 1672 resolved
+23.2% vs TC avg
Minimal -11% lift
Without
With
+-11.0%
Interview Lift
resolved cases with interview
Typical timeline
2y 7m
Avg Prosecution
36 currently pending
Career history
1708
Total Applications
across all art units

Statute-Specific Performance

§101
2.1%
-37.9% vs TC avg
§103
19.1%
-20.9% vs TC avg
§102
19.4%
-20.6% vs TC avg
§112
43.7%
+3.7% vs TC avg
Black line = Tech Center average estimate • Based on career data from 1672 resolved cases

Office Action

§103
Notice of Pre-AIA or AIA Status The present application, filed on or after March 16, 2013, is being examined under the first inventor to file provisions of the AIA . DETAILED ACTION STATUS OF THE CLAIMS: Claims 12-31 are pending in this application. Response to Arguments Applicant’s arguments, filed November 28, 2025, with respect to the rejections of claims under 35 USC § 103 have been fully considered and are persuasive. Therefore, the rejection has been withdrawn. However, upon further consideration, a new ground of rejection is made herein below. Claim Rejections - 35 USC § 103 The following is a quotation of 35 U.S.C. 103 which forms the basis for all obviousness rejections set forth in this Office action: A patent for a claimed invention may not be obtained, notwithstanding that the claimed invention is not identically disclosed as set forth in section 102, if the differences between the claimed invention and the prior art are such that the claimed invention as a whole would have been obvious before the effective filing date of the claimed invention to a person having ordinary skill in the art to which the claimed invention pertains. Patentability shall not be negated by the manner in which the invention was made. The factual inquiries for establishing a background for determining obviousness under 35 U.S.C. 103 are summarized as follows: 1. Determining the scope and contents of the prior art. 2. Ascertaining the differences between the prior art and the claims at issue. 3. Resolving the level of ordinary skill in the pertinent art. 4. Considering objective evidence present in the application indicating obviousness or nonobviousness. Claims 12-31 are rejected under 35 U.S.C. 103 as being unpatentable over Lerg et al., (DE 102017202838). Applicants claim the following cosmetic preparation: PNG media_image1.png 156 582 media_image1.png Greyscale Lerg teaches a similar cosmetic preparation containing a cosmetic oil-in water emulsion containing polyglyceryl-4 and the following: PNG media_image2.png 132 652 media_image2.png Greyscale (See Abstract, paragraph [0001], page 10, lines 1-60, and entire document and translation). Additionally, in paragraph [0044], Lerg discloses the following: PNG media_image3.png 140 640 media_image3.png Greyscale Lerg does not teach the oil-in-water emulsion cometic preparations comprising xanthan gum and hydroxypropyl methylcellulose coupled with the exclusion of polyacrylates. It would have been obvious to one having ordinary skill in the art at the time of the invention to modify the cosmetic preparation in Lerg. One skilled in the art looking for an alternative cosmetic preparation free of polyacrylates, carbomers and polyvinylpyrrolidones would modify the cosmetic preparation of this reference to employ hydroxypropyl methylcellulose and xanthan gum as thickeners especially since these components are widespread in the cosmetic chemical arts and can be established by routine experimentation. It is well known in the art that hydroxypropyl methylcellulose and xanthan gum are widely used as thickeners, stabilizer and emulsifiers, and that they increase viscosity to enhance their texture prevent ingredient separation. Further, it is well known in the art that hydroxypropyl methylcellulose and xanthan gum are effective at low concentration of 0.1-1.0% across a wide pH range. Therefore, one of ordinary skill in the art, confronted with providing an alternative cosmetic preparation free of polyacrylates, carbomers and polyvinylpyrrolidones would modify the cosmetic preparation of this reference to employ hydroxypropyl methylcellulose and xanthan gum as thickeners, especially since these components are widespread in the cosmetic chemical arts and is established by routine and non-inventing experimentation. See In re Payne, 203 USPQ 245(CCPA 1979). Since Applicant’s claims are prima facie obvious in view of the teachings of Lerg, Applicant’s claims are obvious, and therefore, rejected under 35 U.S.C. 103. Conclusion Claims 12-31 are rejected. No claims are allowed. Any inquiry concerning this communication or earlier communications from the examiner should be directed to PAUL V WARD whose telephone number is (571)272-2909. The examiner can normally be reached M-F 9am to 5pm. Examiner interviews are available via telephone, in-person, and video conferencing using a USPTO supplied web-based collaboration tool. To schedule an interview, applicant is encouraged to use the USPTO Automated Interview Request (AIR) at http://www.uspto.gov/interviewpractice. If attempts to reach the examiner by telephone are unsuccessful, the examiner’s supervisor, James Alstrum-Acevedo can be reached at 571-272-5548. The fax phone number for the organization where this application or proceeding is assigned is 571-273-8300. Information regarding the status of published or unpublished applications may be obtained from Patent Center. Unpublished application information in Patent Center is available to registered users. To file and manage patent submissions in Patent Center, visit: https://patentcenter.uspto.gov. Visit https://www.uspto.gov/patents/apply/patent-center for more information about Patent Center and https://www.uspto.gov/patents/docx for information about filing in DOCX format. For additional questions, contact the Electronic Business Center (EBC) at 866-217-9197 (toll-free). If you would like assistance from a USPTO Customer Service Representative, call 800-786-9199 (IN USA OR CANADA) or 571-272-1000. /PAUL V WARD/ Primary Examiner, Art Unit 1622
Read full office action

Prosecution Timeline

Aug 11, 2022
Application Filed
May 12, 2025
Non-Final Rejection — §103
Jul 14, 2025
Response Filed
Aug 26, 2025
Non-Final Rejection — §103
Nov 28, 2025
Response Filed
Mar 24, 2026
Non-Final Rejection — §103 (current)

Precedent Cases

Applications granted by this same examiner with similar technology

Patent 12599666
PHOTOLYTIC COMPOUNDS AND TRIPLET-TRIPLET ANNIHILATION MEDIATED PHOTOLYSIS
2y 5m to grant Granted Apr 14, 2026
Patent 12600705
HEAT SHOCK PROTEIN MODULATORS AND ANTI-HUNTINGTON DISEASE THERAPEUTIC AGENTS
2y 5m to grant Granted Apr 14, 2026
Patent 12600703
METHODS OF SYNTHESIZING FARNESYL DIBENZODIAZEPINONES
2y 5m to grant Granted Apr 14, 2026
Patent 12600700
IMIDAZOLIUM REAGENT FOR MASS SPECTROMETRY
2y 5m to grant Granted Apr 14, 2026
Patent 12599606
THERAPIES WITH 3RD GENERATION EGFR TYROSINE KINASE INHIBITORS
2y 5m to grant Granted Apr 14, 2026
Study what changed to get past this examiner. Based on 5 most recent grants.

AI Strategy Recommendation

Get an AI-powered prosecution strategy using examiner precedents, rejection analysis, and claim mapping.
Powered by AI — typically takes 5-10 seconds

Prosecution Projections

3-4
Expected OA Rounds
83%
Grant Probability
72%
With Interview (-11.0%)
2y 7m
Median Time to Grant
High
PTA Risk
Based on 1672 resolved cases by this examiner. Grant probability derived from career allow rate.

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month